Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00296491 · ClinicalTrials.gov registry record · Phase 4
Study Of Allergic Rhinitis In Patients Who Also Have Asthma
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 725
- Enrollment target
NCT00296491 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 725 participants.
The verdict
NCT00296491, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 725 participants
- Enrollment target
Study Summary
This study will last up to 6 weeks. Subjects will visit the clinic up to 5 times. Certain clinic visits will include a physical examination, medical history review, and lung function tests. All study related medications and medical examinations will be provided at no cost to the subject. The drugs used in this study are approved for the age group under study.
Interventions
- DRUG ADVAIR DISKUS
- DRUG fluticasone propionate/salmeterol (FSC)
- DRUG montelukast (MON)
- DRUG fluticasone propionate (FP)
- DRUG placebo nasal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 725 participants |
| Start Date | 2005-09 |
| Est. Completion | 2007-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00296491
The ClinicalTrials.gov registry entry for NCT00296491 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 725 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which ADVAIR DISKUS is the first listed.
NCT00296491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00296491 about?
NCT00296491 is a clinical study titled "Study Of Allergic Rhinitis In Patients Who Also Have Asthma". This study will last up to 6 weeks. Subjects will visit the clinic up to 5 times. Certain clinic visits will include a physical examination, medical history review, and lung function tests. All study related medications and medical examinations will be provided at no cost to the subject. The drugs u...
What is the current status of trial NCT00296491?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 725 participants. The study started on 2005-09. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00296491?
The interventions under investigation include: ADVAIR DISKUS (DRUG), fluticasone propionate/salmeterol (FSC) (DRUG), montelukast (MON) (DRUG), fluticasone propionate (FP) (DRUG), placebo nasal (DRUG).
Who is sponsoring clinical trial NCT00296491?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.